An anti-ErbB2 fully human antibody circumvents trastuzumab resistance.
Lu Q, Wang L, Zhang Y, Yu X, Wang C, Wang H, Yang Y, Chong X, Xia T, Meng Y, Wang Y, Lu C, Zhou L, Li B.
Lu Q, et al. Among authors: xia t.
Oncotarget. 2016 Oct 11;7(41):67129-67141. doi: 10.18632/oncotarget.11562.
Oncotarget. 2016.
PMID: 27564098
Free PMC article.